Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison

Area of Science:

• Pediatrics
• Immunology
• Infectious Diseases

Background:

• Children infected with SARS-CoV-2 typically show mild symptoms, unlike adults.
• A poorly understood pediatric systemic vasculitis, multisystem inflammatory syndrome in children (MIS-C), is associated with SARS-CoV-2.
• MIS-C shares features with myocarditis, toxic-shock syndrome, and Kawasaki disease.

Purpose of the Study:

• To elucidate the characteristics and immunological underpinnings of MIS-C.
• To differentiate MIS-C from Kawasaki disease based on epidemiological, clinical, and immunological factors.
• To understand the role of exaggerated immune responses and cytokine storms in MIS-C pathogenesis.

Main Methods:

• Review of epidemiological, clinical, and immunological data from MIS-C patients.
• Comparative analysis of MIS-C with Kawasaki disease.
• Investigation of immune cell profiles and cytokine levels in affected children.

Main Results:

• MIS-C is an exaggerated immune response to prior SARS-CoV-2 exposure, characterized by a cytokine storm.
• MIS-C exhibits distinct epidemiological and clinical features compared to Kawasaki disease.
• Key findings include prominent gastrointestinal and cardiovascular involvement, ICU admissions, neutrophilia, lymphopenia, elevated IFNγ, and altered T cell populations (low naive CD4+, high activated memory T cells).

Conclusions:

• MIS-C is a distinct entity from Kawasaki disease, driven by an aberrant immune response post-SARS-CoV-2 infection.
• Understanding MIS-C enhances knowledge of cytokine storm-associated conditions.
• Further research into MIS-C is crucial for managing similar inflammatory syndromes.